JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259203

Human TRANK1 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TRANK1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon11.

View Alternative Names

KIAA0342, LBA1, Lupus brain antigen 1 homolog, TPR and ankyrin repeat-containing protein 1, TRNK1_HUMAN

1 Images
Sanger Sequencing - Human TRANK1 knockout A549 cell lysate (AB259203)
  • Sanger seq

Unknown

Sanger Sequencing - Human TRANK1 knockout A549 cell lysate (AB259203)

Homozygous : 1 bp insertion in exon11

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon11.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259203-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TRANK1 knockout A549 cell lysate", "number":"AB259203-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB259203-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TRANK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TRANK1 also known as Tetratricopeptide Repeat And Ankyrin Repeat Containing 1 is a protein with a mass of approximately 190 kDa. This protein features tetratricopeptide repeats which assist in protein-protein interactions. TRANK1 is expressed widely but higher levels appear in brain tissues. It plays roles in the regulation of several cellular processes through its binding capabilities acting as a modular unit that mediates various cellular interactions.
Biological function summary

Several cellular activities rely on TRANK1 due to its ability to participate in multiprotein complexes. It regulates transcription and cell cycle processes impacting how cells grow and respond to environmental signals. By modulating the activity of other proteins TRANK1 enables cells to maintain homeostasis and adapt to changes. These actions suggest a role in normal brain functions where regulatory precision is needed.

Pathways

The TRANK1 protein interacts within the Wnt signaling and stress response pathways. These pathways involve proteins that regulate gene expression in response to extracellular signals affecting cell fate and proliferation. In the Wnt signaling pathway TRANK1 can influence components like β-catenin impacting processes like cell differentiation. It ensures proper signaling flow affecting cellular responses and maintaining healthy cellular states.

TRANK1 links to psychiatric conditions specifically bipolar disorder and schizophrenia. Research indicates aberrant expression or mutations impair normal brain functionality potentially disrupting emotion regulation and cognitive abilities. TRANK1 associates with proteins like DISC1 which are implicated in brain development and psychiatric disorders suggesting its involvement in neuronal signaling or synaptic functions. Understanding TRANK1 function in these contexts may provide insights into novel therapeutic strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com